Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
59.1%
% of XDNA's 22 holdings also in GNOM
31.7%
% of GNOM's 41 holdings also in XDNA
Overlap by Weight
Sector Drift (XDNA minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XDNA |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
AGILENT TECHNOLOGIES INC | 6.0% | 4.5% | 4.5% |
|
CRISPR THERAPEUTICS AG | 9.2% | 4.0% | 4.0% |
|
INTELLIA THERAPEUTICS, INC. | 9.0% | 3.8% | 3.8% |
|
BEAM THERAPEUTICS, INC. | 8.8% | 3.7% | 3.7% |
|
ILLUMINA INC | 5.3% | 3.7% | 3.7% |
Position Highlights (Non-Overlapping Exposures)
XDNA Overweight Relative to GNOM
|
POSEIDA THERAPEUTICS, INC. | 6.5% |
|
ABBVIE INC | 5.7% |
|
INTELLIA THERAPEUTICS, INC. | 5.3% |
|
CRISPR THERAPEUTICS AG | 5.3% |
|
BEAM THERAPEUTICS, INC. | 5.1% |
|
THERMO FISHER SCIENTIFIC INC | 5.0% |
|
VERVE THERAPEUTICS, INC. | 5.0% |
|
2SEVENTY BIO, INC. | 4.4% |
 |
NOVARTIS AG | 3.7% |
|
CARIBOU BIOSCIENCES, INC. | 3.6% |
XDNA Underweight Relative to GNOM
|
10X GENOMICS INC CLASS A | -5.1% |
 |
BIONTECH SE SPONSORED ADR | -4.5% |
|
BIO-TECHNE CORPORATION | -4.5% |
|
ALNYLAM PHARMACEUTICALS INC | -4.2% |
|
BIOMARIN PHARMACEUTICAL INC | -4.2% |
|
SAREPTA THERAPEUTICS INC | -4.0% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.6% |
|
ULTRAGENYX PHARMACEUTICAL IN | -3.5% |
|
PACIFIC BIOSCIENCES OF CALIF | -3.4% |
 |
GENSCRIPT BIOTECH CORPORATION | -3.4% |